Brigantine Advisors reiterates a 'Buy' on MAKO Surgical (NASDAQ: MAKO), PT $25.

Brigantine analyst says, "Overall, we think Mako continues ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE